Advertisement

Drugs & Therapy Perspectives

, Volume 22, Issue 5, pp 1–4 | Cite as

Tacrolimus ointment is effective in treating atopic dermatitis in adults and children

Drug and Profile Reports

References

  1. 1.
    Bernard LA, Eichenfield LF. Topical immunomodulators for atopic dermatitis. Curr Opin Pediatr 2002 Aug; 14(4): 414–8PubMedCrossRefGoogle Scholar
  2. 2.
    Leung DY, Hanifin JM, Charlesworth EN, et al. Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Work Group on Atopic Dermatitis. Ann Allergy Asthma Immunol 1997 Sep; 79(3): 197–211PubMedCrossRefGoogle Scholar
  3. 3.
    Simpson D, Noble S. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions. Drugs 2005; 65(6): 827–58PubMedCrossRefGoogle Scholar
  4. 4.
    Russell JJ. Topical tacrolimus: a new therapy for atopic dermatitis. Am Fam Physician 2002 Nov 15; 66(10): 1899–902PubMedGoogle Scholar
  5. 5.
    Hanifin JM, Ling MR, Langley R, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part 1, efficacy. J Am Acad Dermatol 2001 Jan; 44(1 Suppl.): S28–38PubMedCrossRefGoogle Scholar
  6. 6.
    Paller A, Eichenfield LF, Leung DYM, et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001; 44(1 Suppl): S47–57PubMedCrossRefGoogle Scholar
  7. 7.
    Reitamo S, for the European Tacrolimus Ointment Study group. 0.1% Tacrolimus ointment is significantly more efficacious than a steroid regimen in adults with moderate to severe topic dermatitis [abstract no. 129055 plus poster]. 1st European Academy of Dermatology and Venerology International Spring Symposium; 2003 Feb 27–Mar 1; St Julian’s, MaltaGoogle Scholar
  8. 8.
    Reitamo S, Rustin M, Ruzicka T, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002 Mar; 109(3): 547–55PubMedCrossRefGoogle Scholar
  9. 9.
    Reitamo S, Van Leent EJ, Ho V, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002 Mar; 109(3): 539–46PubMedCrossRefGoogle Scholar
  10. 10.
    Reitamo S, Harper J, Bos JD, et al. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol 2004 Mar; 150(3): 554–62PubMedCrossRefGoogle Scholar
  11. 11.
    Paller AS, Lebwohl M, Fleischer AB, et al. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol 2005 May; 52(5): 810–22PubMedCrossRefGoogle Scholar
  12. 12.
    Kang S, Lucky AW, Pariser D, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001 Jan; 44(1 Suppl.): S58–64PubMedCrossRefGoogle Scholar
  13. 13.
    Reitamo S, Wollenberg A, Schopf E, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 2000; 136: 999–1006PubMedCrossRefGoogle Scholar
  14. 14.
    Koo JYM, Fleischer A, Pariser D, et al. Tacrolimus ointment 0.1% is safe and effective in the treatment for atopic dermatitis: final results of a large (over 7000 patients) open-label study [abstract no. P22]. 61st Annual Meeting of the American Academy of Dermatology; 2003 Mar 21–26; San Francisco (CA)Google Scholar
  15. 15.
    Paller A, Hanifin J, Eichenfield L, et al. Tacrolimus ointment monotherapy is a safe and effective treatment for atopic dermatitis long-term (more than 3 years) [abstract no. P24]. 61st Annual Meeting of the American Academy of Dermatology; 2003 Mar 21–26; San Francisco (CA)Google Scholar
  16. 16.
    Soter N, Fleischer Jr AB, Webster GF, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safety. J Am Acad Dermatol 2001; 44(1 Suppl.): S39–46PubMedCrossRefGoogle Scholar
  17. 17.
    Fujisawa. Protopic (tacrolimus) ointment 0.03% and 0.1% prescribing information. Deerfield (IL): Fujisawa, 2000Google Scholar

Copyright information

© Adis Data Information BV 2006

Personalised recommendations